Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2025 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of Service
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to The Report
Fundraising

Antithesis

Antithesis Raises $105 million in Series A

105 million
Total Raised
Series A
Latest Round
2018
Founded
150+
Employees
Northern Virginia
Updated December 3, 2025
2 min read

Quick Facts

Valuation
Undisclosed
Latest Round Size
105 million
Latest Round Date
December 2025

Antithesis Raises $105 million in Series A


Antithesis has successfully raised $105 million in a Series A at a Undisclosed led by Jane Street.


Company Overview


Antithesis is a Enterprise Software company headquartered in Northern Virginia, founded in 2018 with 150+ employees.


Antithesis conducts a fully deterministic massively parallel simulation that tests years of real-world production in a few hours. The platform helps companies test complex distributed software systems and has increased revenue by over 12x over the last two years.


Fundraising Details


  • Amount Raised: $105 million
  • Round Type: Series A
  • Valuation: Undisclosed
  • Date: 2025-12-03
  • Investors: Jane Street and Amplify Venture Partners and Spark Capital and Tamarack Global and First In Ventures and Teamworthy Ventures and Hyperion Capital

About Antithesis


Antithesis conducts a fully deterministic massively parallel simulation that tests years of real-world production in a few hours. The platform helps companies test complex distributed software systems and has increased revenue by over 12x over the last two years. The company is positioned in the Enterprise Software sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Northern Virginia
  • Founded: 2018
  • Team Size: 150+
  • Industry: Enterprise Software

What This Means


This funding round demonstrates strong investor confidence in Antithesis's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Enterprise Software sector continues to attract significant investment as companies innovate to meet evolving market demands. Antithesis's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching Undisclosed marks an important milestone for Antithesis, positioning the company among notable players in the Enterprise Software industry.


Looking Ahead


With this new capital, Antithesis is well-positioned to execute on its growth strategy and continue building innovative solutions in the Enterprise Software space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-12-03. For more information about Antithesis, visit their headquarters at Northern Virginia.

Key Investors

Jane Street
Venture Capital
Investor in Antithesis
Amplify Venture Partners
Venture Capital
Investor in Antithesis
Spark Capital
Venture Capital
Investor in Antithesis
Tamarack Global
Venture Capital
Investor in Antithesis
First In Ventures
Venture Capital
Investor in Antithesis
Teamworthy Ventures
Venture Capital
Investor in Antithesis
Hyperion Capital
Venture Capital
Investor in Antithesis

Topics

Fundraising(2912)Enterprise Software(383)Series AAntithesis2025

About the Author

Market Intelligence Team
Market Intelligence Team
Tracking the latest funding rounds and investment news from leading startups and growth companies

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min readβ€’130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min readβ€’120 million